These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2103830)

  • 1. Polymer-metal complexes of protein antigens--new highly effective immunogens.
    Mustafaev MI; Norimov ASh
    Biomed Sci; 1990 Mar; 1(3):274-8. PubMed ID: 2103830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of the immune response to surface antigens of the influenza B virus as a result of their covalent binding with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Biull Eksp Biol Med; 1985 Feb; 99(2):184-6. PubMed ID: 4038611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody-stimulating and protective effect of a conjugate of the influenza virus M protein with a synthetic polymer].
    Petrov RV; Zhdanov VM; Khaitov RM; Norimov ASh; Nekrasov AV
    Dokl Akad Nauk SSSR; 1984; 277(3):720-2. PubMed ID: 6489115
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccinating effect of conjugates of influenza virus surface antigens with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Dokl Akad Nauk SSSR; 1984; 277(3):752-5. PubMed ID: 6489120
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccines.
    Petrov RV; Khaitov RM; Zhdanov VM; Sinyakov MS; Norimov ASh; Nekrasov AV; Podchernyaeva RYa ; Kharitonenkov IG; Shchipanova MV
    Vaccine; 1985 Dec; 3(5):392-400. PubMed ID: 3936300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.
    Ernst WA; Kim HJ; Tumpey TM; Jansen AD; Tai W; Cramer DV; Adler-Moore JP; Fujii G
    Vaccine; 2006 Jun; 24(24):5158-68. PubMed ID: 16713037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
    Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.
    Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY
    Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
    Wedlock DN; Skinner MA; de Lisle GW; Vordermeier HM; Hewinson RG; Hecker R; van Drunen Littel-van den Hurk S; Babiuk LA; Buddle BM
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):53-63. PubMed ID: 15910992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
    Dennehy M; Bourn W; Steele D; Williamson AL
    Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
    Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant BCG as an antigen delivery system.
    Flynn JL
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.